Cavers Greg bought HELP
September 29, 2026 · Form 4 insider transaction
Cavers Greg bought 3,000 shares of Cybin D/B/A Helus Pharma at $12.91 per share, a transaction worth $38.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$12.91
Total value
$38.7K
InsiderCavers Greg
RoleOfficer
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateSeptember 29, 2026
Filing dateOctober 1, 2026
Shares owned after3,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Converted from Canadian purchase price of C$18.3157 using an exchange rate of C$1.4188 = US$1.00.